Bruce Culleton - 13 Sep 2024 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: PROK
Reported as of: 13 Sep 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Sep 2024, 17:31:15 UTC
Prior SEC filing: 05 Dec 2023
Next SEC filing: 04 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Todd Girolamo, attorney in fact

Key filing fact

Bruce Culleton filed Form 4 for PROKIDNEY CORP. (PROK) on 16 Sep 2024.

Key facts

This page summarizes Bruce Culleton's Form 4 filing for PROKIDNEY CORP. (PROK).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 16 Sep 2024, 17:31.

Change

Previous filing in this sequence was filed on 05 Dec 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PROK transaction Derivative

Employee stock option (right to buy)

Award

Transaction value: $0
Shares: +500,000
Change %
Price: $0.000000
Shares after: 500,000
Date: 13 Sep 2024
Ownership: Direct
Underlying class: Class A Ordinary Shares
Underlying amount: 500,000
Exercise price: $1.69
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This performance-based stock option was granted on December 3, 2023. On September 13, 2024, the Company's board of directors certified achievement of the performance goal at 100%. In addition to the achievement of the performance goal, the options are subject to time vesting requirements under which 25% vested on September 13, 2024 and the remaining 75% vests in equal installments of 125,000 shares on each of November 15, 2024, February 15, 2025 and May 15, 2025.